# Alterola Biotech, Inc. (ABTI)

> Healthcare · GB · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ABTI/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -910.4K | $ -234.1K | $ 1.55M | $ -2.02M |
| 2023 | $ 0 | $ -1.02M | $ -1.12M | $ 1.41M | $ 10.10M |
| 2022 | $ 0 | $ -7.23M | $ 49.5K | $ 164.2K | $ 10.93M |
| 2021 | $ 0 | $ -300.1K | $ 113.6K | $ 270.4K | $ 0 |
| 2020 | $ 0 | $ -288.1K | $ 163.7K | $ 0 | $ -266.2K |
| 2019 | $ 0 | $ -639.6K | $ -90.6K | $ 0 | $ -126.0K |
| 2018 | $ 0 | $ -89.6K | $ 4.7K | $ 175.0K | $ -306.4K |
| 2017 | $ 0 | $ -33.2K | $ 9.1K | $ 175.0K | $ -275.6K |
| 2016 | $ 0 | $ -41.8K | $ -43.1K | $ 175.0K | $ -250.9K |
| 2015 | $ 0 | $ -55.8K | $ -19.1K | $ 150.0K | $ -220.5K |
| 2014 | $ 0 | $ -136.7K | $ -71.8K | $ 130.0K | $ -180.8K |
| 2013 | $ 0 | $ -18.8K | $ -88.2K | $ 80.0K | $ -121.0K |
| 2012 | $ 0 | $ -48.9K | $ -17.3K | $ 80.0K | $ -107.8K |
| 2011 | $ 0 | $ -241.5K | $ -193.0K | $ 80.0K | $ -85.9K |
| 2010 | $ 0 | $ -99.3K | $ -100.0K | $ 0 | $ 12.0K |
| 2009 | $ 0 | $ -113.2K | $ -117.8K | $ 0 | $ 27.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.77 |
| Liabilities / Eq | -1.25 |
| Current Ratio | 0.08 |

## Other views

- [Metrics](https://sponda.capital/en/ABTI.md)
- [Charts](https://sponda.capital/en/ABTI/charts.md)
- [Compare](https://sponda.capital/en/ABTI/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.